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Niacinamide leave-on formulation provides long-lasting protection against bacteria in vivo Abstract
Antimicrobial peptides (AMPs) form a part of the skin's innate immune system. Their primary activity is to provide antimicrobial benefits and hence protect from infections. AMPs that are present on human skin include psoriasin (S100A7), RNase 7, lysozyme, LL-37 and defensins. Niacinamide is a well-known cosmetic ingredient that has been used traditionally for multiple skin benefits.
Recent data indicate that niacinamide treatment can boost AMPs in human gut epithelial cells and in neutrophils. Treatment with niacinamide in mice also provided protection from skin infections by enhancing AMPs. In this article, we find that treatment with niacinamide formulation provides long-lasting protection against bacteria, potentially through the activation of an AMP response.
| BACKGROUND
Skin is an immunologically active organ and harbours immune mediators from the innate and adaptive branches of immunity. Skin innate immunity is critical for cutaneous defense and antimicrobial peptides (AMPs) form a part of the skin's innate immune system. Primary activity of the AMPs is to provide antimicrobial benefits and protect from infections. [1, 2] Niacinamide is a well-known cosmetic ingredient that has been used traditionally for skin lightening, anti-ageing and skin barrier building benefits. [3, 4] Recent data indicate that niacinamide treatment can boost AMPs in gut epithelial cells and in neutrophils. [5, 6] Treatment with niacinamide in mice also provided protection from infections through the boost of AMPs. [6] Based on these studies, we hypothesized that niacinamide can elicit similar responses in human skin resulting in enhanced antimicrobial protection and boosting AMP in skin cells.
| QUESTION ADDRESSED
To evaluate the effect of a niacinamide containing formulation in providing antimicrobial benefits to human skin.
| EXPERIMENTAL DESIGN
Supplementary section Data S1. [7] . Given that we were interested in investigating antimicrobial benefits through AMPs, we measured bacterial survival 6 hours after the application of the niacinamide formulation in vivo.
As shown in Figure 1A , B, we found that formulation with niacinamide significantly improved skin's own antimicrobial response and provided superior bacterial kill (E. coli and S. aureus) 6 hours after application in vivo. This was an interesting result as it showed for the first time that niacinamide containing formulation provided long-lasting antimicrobial benefits. These long-lasting antimicrobial benefits as observed can either result from a skin biological response involving the AMPs, or alternatively, can occur from direct antimicrobial action of the niacinamide or other formulation components deposited onto the skin.
To rule out the possibility of direct antimicrobial action of niacinamide or other formulation ingredients, E. coli kill was measured using two different in vitro protocols. Pure niacinamide was added to bacterial growth medium, and E. coli survival was assessed. Additionally, niacinamide formulations were applied on artificial skin which again contains no biological materials. Six hours after application, E. coli survival was measured. As shown in Figure S1A , B, neither niacinamide formulations nor pure niacinamide exhibited direct antimicrobial effect against E. coli. Similar to E. coli, niacinamide formulations did not impact S. aureus survival in vitro (data not shown). Taken together, data clearly indicated that niacinamide formulations tested in the human volunteer study had no direct effect on bacterial survival. The enhanced bacterial kill observed in Figure 1A , B required skin components potentially an AMP response for the antimicrobial activity.
The next logical step was to test the ability of niacinamide to enhance the AMP levels in skin cells. For this purpose, we used primary skin keratinocytes and investigated AMP levels after niacinamide treatment in vitro. As psoriasin is known to be the major skin AMP for protection against E. coli, we measured psoriasin levels. As shown in Figure 2A , niacinamide treatment enhanced psoriasin secretion from primary skin keratinocytes. We also looked at psoriasin boost using E. coli supernatant as a positive control both in vitro and in vivo and additionally monitored E. coli survival on the forearm in vivo. As shown in Figures S2A and S1C , E. coli supernatant treatment boosted psoriasin both in vitro and in vivo. As shown in 
| DISCUSSIONS
Our data presented in this article shows for the first time that a niacinamide containing formulation can boost the skin's antimicrobial properties and provide protection from bacteria 6 hours after formulation application in vivo. We also showed that niacinamide treatment boosts AMPs, which again is in agreement with published literature from Kyme et al. [6] and Hashimoto et al. [5] In our study, we have only measured secretion of psoriasin as a representative AMP, while gene expression of other cutaneous AMPs like RNase 7 and calprotectin was measured in vitro. Future studies will be required where secretion kinetics of multiple AMPs and other skin antimicrobial components needs be tested to gain further insights into the mode of action. While psoriasin is critical for protection against E. coli, we cannot rule out the modulation of other AMPs by niacinamide. Additionally, niacinamide is known to activate multiple cellular pathways, which again can collectively lead to the protection from bacteria along with innate immune activation. Therefore, further work will be required to fully understand the complete mode of action of niacinamide and its hygiene benefit on skin.
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